Counterpoint Mutual Funds’s Xylem XYL Stock Holding History

Counterpoint Mutual Funds’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,418	Closed	-$357K	–	509
2025 Q3	$357K	Buy	+2,418	New	+$335K	0.03%	248

Other funds holding XYL

JSC

J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Counterpoint Mutual Funds's XYL Position: Q4 2025 in Review

Counterpoint Mutual Funds sold out of Xylem (XYL) in Q4 2025, closing a stake of 2,418 shares — an estimated $357K sold.

Counterpoint Mutual Funds first reported a position in XYL in Q3 2025 and held it in 1 quarter. The position peaked at $357K in Q3 2025. 1,131 funds tracked by Wall St. Rank hold XYL as of Q4 2025.

Counterpoint Mutual Funds reported no remaining Xylem position as of Q4 2025 after selling out during the quarter.
Counterpoint Mutual Funds sold 2,418 Xylem shares in Q4 2025, an estimated $357K.
Counterpoint Mutual Funds first reported a position in Xylem in Q3 2025 and held it in 1 quarter.
Counterpoint Mutual Funds's Xylem position peaked at $357K in Q3 2025.
1,131 funds tracked by Wall St. Rank held Xylem as of Q4 2025.

Based on Counterpoint Mutual Funds's 13F filing for Q4 2025, filed 12 Feb 2026.